Page last updated: 2024-11-05

thalidomide and Leukoma

thalidomide has been researched along with Leukoma in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mesa-Gutiérrez, JC1
Rouras-López, A1
Amías-Lamana, V1
Hoyos-Chacón, J1
Cabiró-Badimón, I1
Porta-Monnet, J1
Huang, YH1
Tseng, SH1

Other Studies

2 other studies available for thalidomide and Leukoma

ArticleYear
[Crystalline keratopathy due to kappa chains in a monoclonal gammopathy].
    Archivos de la Sociedad Espanola de Oftalmologia, 2013, Volume: 88, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Combined Modality Therapy; Corn

2013
Corneal snowflakes.
    Lancet (London, England), 2012, Aug-04, Volume: 380, Issue:9840

    Topics: Antineoplastic Agents; Biopsy; Bone Marrow; Cornea; Corneal Opacity; Crystallins; Diagnosis, Differe

2012